Hualan Biological Engineering Inc. - Income Statement (TTM)

Hualan Biological Engineering Inc.
CN ˙ SZSE ˙ CNE000001JN8
CN¥16.83 ↑0.33 (2.00%)
2025-09-05
SHARE PRICE
Income Statement (TTM)

Hualan Biological Engineering Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2022
01-01
2022
03-31
2022
06-30
2022
09-30
2023
01-01
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 4,134 5,023 4,969 4,925 5,311 4,436 4,453 5,497 4,677 4,517 4,757 3,753 4,828 5,342 5,249 5,409 4,920 4,379 4,460 4,525
Change (%) 21.50 -1.08 -0.88 7.84 -16.48 0.39 23.43 -14.91 -3.43 5.31 -21.11 28.64 10.65 -1.75 3.06 -9.05 -10.98 1.83 1.46
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 1,368 1,405 1,372 1,361 1,453 1,538 1,563 1,778 1,689 1,699 1,772 1,576 1,700 1,727 1,751 1,906 1,873 1,768 1,799 1,800
Change (%) 2.68 -2.37 -0.75 6.78 5.82 1.60 13.80 -5.05 0.63 4.27 -11.06 7.92 1.56 1.37 8.86 -1.70 -5.61 1.72 0.07
% of Revenue 33.10 27.97 27.60 27.64 27.36 34.67 35.09 32.35 36.10 37.62 37.24 41.99 35.22 32.33 33.35 35.23 38.08 40.38 40.33 39.78
Gross Operating Profit 2,766 3,618 3,598 3,564 3,858 2,898 2,891 3,719 2,989 2,818 2,985 2,177 3,127 3,615 3,498 3,504 3,046 2,611 2,661 2,725
Change (%) 30.81 -0.58 -0.93 8.25 -24.88 -0.25 28.64 -19.62 -5.72 5.94 -27.07 43.64 15.60 -3.24 0.16 -13.05 -14.29 1.91 2.40
% of Revenue 66.90 72.03 72.40 72.36 72.64 65.33 64.91 67.65 63.90 62.38 62.76 58.01 64.78 67.67 66.65 64.77 61.92 59.62 59.67 60.22
SG&A 1,027 1,371 1,344 1,358 1,482 1,022 1,008 1,604 1,258 1,238 1,297 734 1,299 1,479 1,455 1,473 1,210 1,061 1,044 1,064
Change (%) 33.40 -1.94 1.01 9.17 -31.03 -1.38 59.08 -21.55 -1.59 4.77 -43.43 77.05 13.85 -1.63 1.26 -17.86 -12.35 -1.61 1.94
% of Revenue 24.85 27.28 27.05 27.56 27.90 23.04 22.63 29.17 26.90 27.41 27.27 19.55 26.91 27.69 27.72 27.24 24.60 24.22 23.40 23.51
R&D 184 213 235 257 259 254 263 280 284 315 329 310 311 281 276 280 275 333 327 350
Change (%) 15.73 10.16 9.36 0.79 -2.04 3.61 6.52 1.51 10.75 4.39 -5.50 0.04 -9.57 -1.73 1.54 -1.90 21.20 -1.88 7.02
% of Revenue 4.46 4.24 4.73 5.22 4.87 5.72 5.90 5.09 6.08 6.97 6.91 8.27 6.43 5.26 5.26 5.18 5.59 7.61 7.33 7.73
OpEx 2,575 3,026 2,981 3,016 3,263 2,850 2,878 3,712 3,276 3,294 3,438 2,654 3,350 3,531 3,521 3,702 3,404 3,200 3,218 3,255
Change (%) 17.50 -1.49 1.19 8.18 -12.66 0.98 28.97 -11.75 0.55 4.39 -22.80 26.21 5.42 -0.31 5.16 -8.07 -5.97 0.55 1.14
% of Revenue 62.29 60.24 59.99 61.24 61.43 64.24 64.62 67.52 70.03 72.92 72.28 70.73 69.39 66.11 67.08 68.45 69.18 73.08 72.16 71.93
Operating Income 1,559 1,997 1,988 1,909 2,049 1,586 1,576 1,785 1,402 1,223 1,319 1,098 1,478 1,810 1,728 1,707 1,516 1,179 1,241 1,270
Change (%) 28.12 -0.45 -3.98 7.31 -22.57 -0.68 13.31 -21.49 -12.72 7.80 -16.71 34.52 22.52 -4.56 -1.22 -11.19 -22.24 5.32 2.29
% of Revenue 37.71 39.76 40.01 38.76 38.57 35.76 35.38 32.48 29.97 27.08 27.72 29.27 30.61 33.89 32.92 31.55 30.82 26.92 27.84 28.07
Interest Expense -10 -5 -7 -7 -10 -22 -26 -31 -34 -30 -26 -21 -15 -13 -14 -15 -15 -13 -11 -10
Change (%) -51.22 39.72 -5.84 48.41 123.89 21.64 19.13 8.00 -10.98 -14.08 -20.17 -27.65 -12.30 5.79 8.62 0.77 -15.12 -13.63 -8.49
% of Revenue -0.25 -0.10 -0.14 -0.13 -0.18 -0.49 -0.59 -0.57 -0.73 -0.67 -0.55 -0.55 -0.31 -0.25 -0.27 -0.28 -0.31 -0.30 -0.25 -0.23
Net Income 1,284 1,613 1,621 1,559 1,709 1,299 1,277 1,425 1,139 1,076 1,194 1,020 1,243 1,482 1,392 1,395 1,338 1,088 1,139 1,164
Change (%) 25.65 0.50 -3.85 9.66 -24.01 -1.65 11.52 -20.04 -5.52 10.95 -14.58 21.87 19.20 -6.07 0.25 -4.10 -18.69 4.72 2.13
% of Revenue 31.05 32.11 32.62 31.65 32.18 29.28 28.68 25.92 24.35 23.83 25.10 27.18 25.75 27.74 26.52 25.79 27.20 24.84 25.55 25.71

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista